Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10?854 patients from the CHAMPION PHOENIX trial.

Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10?854 patients from the CHAMPION PHOENIX trial. Eur Heart J. 2018 12 07; 39(46):4112-4121.

View in: PubMed

subject areas

Adenosine Monophosphate
Aged
Coronary Angiography
Dose-Response Relationship, Drug
Double-Blind Method
Female
Follow-Up Studies
Humans
Incidence
Infusions, Intravenous
Male
Middle Aged
Myocardial Ischemia
Percutaneous Coronary Intervention
Perioperative Care
Postoperative Complications
Purinergic P2Y Receptor Antagonists
Retrospective Studies
Risk Factors
Survival Rate
Treatment Outcome
United States

authors with profiles

Robert Harrington